- Report
- January 2024
- 200 Pages
Global
From €3987EUR$4,150USD£3,409GBP
- Report
- February 2021
- 500 Pages
United States
From €2306EUR$2,400USD£1,972GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3459EUR$3,600USD£2,957GBP
- Report
- February 2024
- 70 Pages
Saudi Arabia
From €4564EUR$4,750USD£3,902GBP
- Report
- October 2019
- 125 Pages
Canada
From €4564EUR$4,750USD£3,902GBP
- Report
- November 2018
- 30 Pages
China
From €2114EUR$2,200USD£1,807GBP
- Report
- January 2021
- 137 Pages
China, Global
From €3000EUR$3,345USD£2,655GBP
Glimepiride is a drug used to treat type 2 diabetes, a condition in which the body does not produce or use insulin properly. It belongs to a class of drugs known as sulfonylureas, which work by stimulating the pancreas to produce more insulin. Glimepiride is used in combination with diet and exercise to help control blood sugar levels. It is also used to reduce the risk of cardiovascular disease in people with type 2 diabetes.
Glimepiride is a widely used drug in the endocrine and metabolic disorders drugs market. It is used to treat type 2 diabetes, a condition that affects millions of people worldwide. It is a cost-effective and safe treatment option for many patients. It is also used to reduce the risk of cardiovascular disease in people with type 2 diabetes.
Some companies in the glimepiride market include Sanofi, Novo Nordisk, Merck, and Eli Lilly. Show Less Read more
